X0508 4 2024-02-20 0000887359 Vericel Corp VCEL 0001313403 Colangelo Dominick 64 SIDNEY STREET CAMBRIDGE MA 02139 true true President and CEO false Common Stock 2024-02-20 4 M 0 18250 0 A 192258 D Common Stock 2024-02-20 4 F 0 8459 49.5 D 183799 D Common Stock 2024-02-20 4 M 0 11700 0 A 195499 D Common Stock 2024-02-20 4 F 0 5423 49.5 D 190076 D Common Stock 2024-02-20 4 M 0 8937 0 A 199013 D Common Stock 2024-02-20 4 F 0 4143 49.5 D 194870 D Restricted Stock Unit 2024-02-20 4 M 0 18250 A Common Stock 18250 54750 D Restricted Stock Unit 2024-02-20 4 M 0 11700 A Common Stock 11700 23400 D Restricted Stock Unit 2024-02-20 4 M 0 8937 A Common Stock 8937 8938 D The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 17, 2023. The remaining RSUs will vest in annual installments on February 17, 2025, February 17, 2026, and February 17, 2027, respectively. These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs. The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 18, 2022. The remaining RSUs will vest in annual installments on February 18, 2025, and February 18, 2026, respectively. The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 19, 2021. The remaining RSUs will vest on February 19, 2025. Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. No expiration date for this type of award. The Fair Market Value of the vested derivative securities is $49.50 per share. /s/ Sean Flynn, as Attorney-in-Fact for Dominick C. Colangelo 2024-02-22